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CryogelationFor the first time, macroporous, elastic, three-dimensional hyaluronic acid cryogels were prepared with
genipin as non-cytotoxic crosslinking agent. These cryogels are characterized by a lamellar porous struc-
ture with a homogeneous pore size of ~100 mm, shear elasticity of ~2 kPa and a swelling ratio of 2.5 in
water. Additionally, multiple particle tracking based microrheology measurements reveal the formation
of a heterogeneous network. This novel biomaterial owns great potential as non-cytotoxic alternative for
application in drug delivery, as tissue engineering scaffold or wound healing substrate and can help
reducing toxicity of artificial skin grafts or tissue equivalents.
 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction technique. Thus, we compared the swelling capacity, structural,For successful tissue engineering, a scaffold must be biofunc-
tional, biodegradable, biocompatible, with a 3D porous architec-
ture and high degree of pore interconnectivity. Furthermore, it
should have appropriate mechanical properties to closely mimic
mechanical, and ideally also chemical properties of the extracellu-
lar matrix. For fabrication of hyaluronic acid (HA) based-scaffolds,
phase separation [1], freeze-drying [2] and electrospinning [3]
have been established. Therefore, BDDE (1,4-butanediol diglycidyl
ether) [4] and glutaraldehyde [1] were used as crosslinkers. The
fabrication of one-component HA scaffolds via cryogelation [5]
facilitates the formation of homogeneous pores at a relatively
low polymer concentration. Crosslinkers that are reactive with
HA at low temperatures are ethyleneglycol diglycidylether (EGDE)
[6–8] and EDC/NHS (carbodiimide/N-hydroxysuccinimide) [9].
Mixed cryogels of HA with collagen, gelatine and chitosan were
also crosslinked by EDC/NHS [10] and glutaraldehyde [11,12]. Most
of the crosslinkers and especially their non-reacting residues are
cytotoxic [13,14]. It is consequently desirable to use non-
cytotoxic crosslinkers to form stable and biocompatible HA based
hydrogels. Genipin is a natural product extracted from the garde-
nia fruit and it was shown that its cytotoxicity is significantly
lower than that of common crosslinkers [15–20]. Genipin has been
utilized to crosslink biopolymers, such as chitosan [19] and gela-
tine [20] or hybrid systems like chitosan/HA [21] but it has never
been used to form pure HA gels before. We now proved the suit-
ability of genipin as an alternative crosslinking agent for the fabri-
cation of one component HA porous gels using the cryogelationmicro- and macro-viscoelastic properties of HA scaffolds cross-
linked with genipin to the corresponding features of such gels
crosslinked with commonly used EGDE.
2. Materials and methods
2.1. Preparation of cryogels and determination of swelling capacity
Macroporous gels were prepared using the cryogelation tech-
nique as previously described [8]. Briefly, HA (Mw = 2.0 to 2.2
Mio Da, Contipro) was dissolved in 1% NaOH and EGDE was added.
For genipin crosslinking, HA was dissolved in PBS and mixed 2:1
with genipin in DMSO (20 mg/ml, considering the maximum solu-
bility). After mixing for 20 min, solutions were frozen at 20 C for
6 days. After thawing, the swelling ratio (SR) was determined by
measuring the ratio of the mass of the gel equilibrated in water
and un-swollen state.
2.2. Rotational rheometry
Gel bulk linear viscoelastic properties were characterized per-
forming oscillatory shear experiments in the linear-viscoelastic
regime, using a rotational rheometer Anton Paar MCR 501 (plate/
plate, diameter 8 mm, gap 1 mm).
2.3. Multiple particle tracking
Local viscoelastic properties of the matrix, namely the pore
walls, were investigated using the multiple particle tracking
(MPT) technique [22,23]. In MPT experiments, the thermally driven
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sample is monitored. Here, we tracked the Brownian motion of
green fluorescent polystyrene microspheres (diameter 0.19 lm).
For performing measurements exclusively in the matrix, particles
were added to the polymer solutions before freezing. The displace-
ments of particle centers were monitored at a rate of 50 frames/s.
Movies of the fluctuating microspheres were analyzed using a cus-
tom MPT routine, incorporated into the software Image Processing
System (Visiometrics iPS) and a self-written Matlab program [24],
based on the widely used Crocker and Grier algorithm [25].Fig. 2. Dynamic shear moduli G0 (closed symbols) and G00 (open symbols) of 3 wt%
HA gels crosslinked with EGDE (blue) and genipin (red). (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of
this article.)
Table 1
Crosslinker concentrations in a 3 wt% HA hydrogel.
Crosslinker Concentration/wt% Reactive groups/
mMol/ml
Solvent
EGDE 0.7 40 1% NaOH
Genipin 0.5 20 PBS with 30% DMSO3. Results and discussion
3.1. Cryogels structural properties and swelling capacity
Independent of the crosslinker used, both types of cryogels
obtained were spongy, elastic with large pores and they swelled
instantaneously when immersed in water. Examples of 3D images
of the structure of these cryogels in the wet state, obtained with
laser scanning microscopy (LSM 510, Carl Zeiss), are shown in
Fig. 1.
EGDE cryogels show interconnected round pores of size
~100 lm and thin matrix wall of ~5–20 lm [8]. For genipin cryo-
gels, the images suggest the formation of a more lamellar porous
structure with a pore size almost similar to that of EGDE gels. To
our knowledge, this is the first time that pure HA hydrogels have
been fabricated with non-cytotoxic crosslinker genipin. Different
crosslinking mechanisms are the origin of the formation of these
two morphologically different gels. In HA/EGDE gels, epoxy groups
of the EGDE are covalently bond to the HA hydroxyl groups under
alkaline conditions [6]. Genipin generally reacts with primary
amino groups of biopolymers but HA does not have such groups.
However, HA has multiple highly reactive hydroxy groups that
are able to form e.g. glycosidic bonds, presumably with genipin
[26]. The latter are known to be stable as seen in other polycarbo-
hydrates, such as starch. Other gels, based on non-covalent bonds,
are known to be stable in water, too. [27]. Although the crosslink-
ing mechanism cannot be fully unravelled here, cryogelation of HA
and genipin leads to stable intermolecular bonds, that are strong
enough to allow for the swelling of HA/genipin gels in water with-
out dissolving. Without genipin, no stable structures can be
obtained.
Despite the higher molar ratio of crosslinker to polymer,
HA/EGDE gels exhibit a higher degree of swelling with SR  7.5
compared to HA/genipin gels with SR  2.5. This may be due to a
heterogeneous gel structure with percolating domains of highFig. 1. LSM images of gels structures, crosslinked with EGDE and genipin, vicrosslink density that limits the swellability of genipin gels. After
immersion in water, both compositions show high long-term sta-
bility (several months) and shape fidelity, which can be considered
mandatory in tissue engineering applications.
3.2. Mechanical properties
In bulk oscillatory shear measurements, gels of both composi-
tions show frequency independent elastic moduli and G0 domi-
nates over G00 in the frequency range from 0.1 to 10 rad/s (Fig. 2).sualized by fluorescence of tracer particles embedded in the pore walls.
Fig. 3. MSDs of PS particles (d = 0.19 lm) dispersed in the matrix of HA 3 wt% gels crosslinked with EGDE (A) and genipin (B). Blue and red curves are the ensemble-averaged
MSD.
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shear elastic plateau modulus data G0 (average of G0 values
obtained in the probed frequency range) show that the less swollen
gel made of genipin provides a higher elastic modulus value
G0 ~ 2000 Pa compared to the highly swollen EGDE gel where
G0 ~ 200 Pa. This is direct evidence of the different crosslink den-
sity of the swollen gels. The three-times lower water uptake of
the genipin gel outweighs the two-times lower molar ratio of
crosslinker to polymer compared to the EGDE gel (see Table 1
and see 3.1).
In order to characterize the local elasticity of the pore walls,
microstructural and local viscoelastic properties of the gels were
investigated by means of MPT microrheology. Fig. 3 shows the
variation of mean square displacements (MSDs) as a function of
lag time s for tracer particles with diameter 0.19 mm dispersed in
the gel network. In both cases, almost no time dependence of the
individual MSDs is found and this result indicates that particles
are highly constrained by the surrounding fluid which is consistent
with an elastic trapping of particles in a gel-like network.
Additionally, for gels crosslinked with genipin (Fig. 3B), the
range of displacements at a given lag time is much broader than
for the gel crosslinked with EGDE (Fig. 3A). At s = 0.1 s, MSDs vary
about two orders of magnitude, from ~3.104 to 102 lm2 for gen-
ipin gels compared to only one order of magnitude from ~5.105 to
7.104 lm2 for EGDE gels.
This indicates a more heterogeneous structure of the
HA/genipin network with a non-Gaussian parameter [28] a = 5.5,
compared to the HA/EGDE gel where a = 1.4. As already mentioned
above, this might be the reason for the reduced swelling capacity of
genipin gels (see 3.1). The higher absolute value of the average
MSD for genipin gels indicates that particles explore a softer envi-
ronment than in EGDE gels. The discrepancy between micro- and
macrorheology which is more pronounced for genipin than for
EGDE hydrogels, is presumably due to densely crosslinked regions
in the more heterogeneous genipin hydrogels, that are inaccessible
for tracer particles but seem to contribute to the overall mechani-
cal strength of the constructs.4. Conclusion
Genipin can be used as crosslinking agent for producing non-
cytotoxic macroporous hyaluronic acid cryogels. Bulk elasticity of
genipin and conventional EDGE gels are in the same range,whereas the local mechanical properties of genipin gels are more
heterogeneous. Both gels show similar pore sizes in a well-
suitable range for cell culture applications. In genipin gels, the
pores appear more lamellar, but the major advantage of using gen-
ipin as crosslinking agent is its low cytotoxicity that allows the for-
mation of stable cryogels with a broad range of potential
applications, e.g. as cell culture scaffold, in drug delivery or wound
healing.Declaration of Competing Interest
The authors declare that they have no known competing finan-
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